Does Synergy CHC Corp. have an economic moat?

Based on its FY2025 SEC filings, the Moat Index scores Synergy CHC Corp. (SNYRQ) 42.3 out of 100 — a Shallow moat. The five questions behind that score begin at 20% each; if exactly one genuinely lacks data, the other four weights are renormalized and disclosed. revenue and EPS trend 0, pricing power 85, returns on capital 75, balance-sheet safety 28, capital allocation 24.

How has SNYRQ's Moat Score changed over time?

The record logs 1 reading since Sep 30, 2026; the latest reads 42.3 out of 100 (shallow moat). No tier changes on record yet. The history is append-only — readings are only ever added, never rewritten.

Synergy CHC Corp.

SNYRQ · Healthcare · FY2025 filings · as of Sep 30, 2026 · Shallow moat ·

Doesn't clear the bar

Shallow moat

The five investor questions

2023–2025 (latest 3 aligned FYs; v3 window cap 5): revenue $42.8M to $30.4M, decreasing; diluted EPS 0.86 to -1.27, decreasing. Latest-filed diluted EPS remains usable for Business Trend, but an integer share-count change lacks enough evidence to confirm a comparable EPS basis; valuation growth therefore stays at 0%.

Median gross margin 67.9% over 9y, stable.

Median ROIC 15.8%, above the 12% hurdle in 80% of years.

Net debt/EBITDA n/ax, interest coverage -1x.

Owner earnings changed trend unclear over up to the ten most recent annual observations.

Price vs. value if growth stopped today

A cautious baseline, not a price target: what the shares may support if normalized owner earnings simply hold steady.

Above value if growth stopped todayBelow value if growth stopped today

No price data

: Not reported
: Unavailable — insufficient owner-earnings data
: Unavailable — insufficient growth-model data
: Unavailable — no recent price
: No price data

This zero-growth estimate assumes trailing owner earnings persist — unreliable for declining businesses. Flag status unavailable — four adjacent recent FY revenue observations are required.

Among the current top-score group, the median current price is 212% above the zero-growth estimate across 49 of the current top 50 companies by Moat Score with both values.

Score records captured Sep 29, 2026.

Exactly which 50 companies?

FTNT, IBEX, META, MEDP, MSFT, GOOG, LULU, ANF, IDXX, TXRH, FHI, QLYS, FFIV, ADBE, LLY, MANH, CPRT, VEEV, RMD, GRMN, PCTY, EAT, UI, SSD, MNST, DOCS, LRCX, MCO, NTAP, NVDA, CORT, SFM, MPTI, ULTA, SN, ROL, CTAS, PAYC, IRMD, DECK, MORN, INTU, JKHY, TPR, LGCY, DAL, GWW, ISRG, MPWR, LOPE

Missing a usable price or zero-growth estimate: ANF.

Model details under moat-index@3.0.0: zero-growth multiple 11.1×, capped-growth comparison at no more than 18×; 9% discount rate; high-end growth 0% (capped at 4%) using min(5y revenue CAGR, 5y diluted-EPS CAGR), clamped to 0%–4%; maintenance capex uses min(capex, D&A); abstain when D&A is unavailable. This is a disclosed model range, not intrinsic value as fact.

12 years of fundamentals

The business, in plain English

Synergy CHC Corp. booked $30.4M of revenue in FY2025 in the Healthcare sector and kept 66.8% of it as gross profit — a high-margin business by that measure. After every other cost, −40.6% of each revenue dollar reached the bottom line.

Across the filed record, revenue grew from $9158 (FY2014) to $30.4M (FY2025) — about 109.0% a year compounded over 11 years.

ROIC is not available for the latest filed year, FY2025. Across the full 5-year measurable filed record, median ROIC was 15.8%. Over the v3 recent window (5 measurable filed years), median ROIC was 15.8%. The Returns on Capital filter above scores it 75/100.

The balance sheet carried $25.1M of total debt in FY2025. Balance-Sheet Safety scores it 28/100.

Put together: Pricing Power is the strongest of the five filters (85/100) and Business Trend the weakest (0/100), which is how SNYRQ lands at 42/100 — a Shallow moat.

This breakdown is generated from the filed numbers and sub-scores above — no outside narrative, no estimates. Where a filing doesn’t disclose an input, the sentence that would need it is omitted instead of guessed.

Sales, as filed$30.4M FY2025

Revenue kept after cost of goods66.8% FY2025

Standard ROIC or separately labeled Operating ROICStandard ROIC −1447.1% FY2025

Exact FY and FY-1 financing invested-capital inputs are required.. Exact FY and FY-1 Operating Invested Capital inputs are required.. Not meaningful FY2025: invested capital is negative (cash exceeds debt + equity)

Cash an owner could take out−$12.3M FY2025

The explained ROIC gaps have filed inputs but no meaningful positive invested-capital denominator. Other gaps mean the item is not in the filings for that year. The series is never interpolated or estimated. The Table view lists every filed value, including operating and net margins, total debt, and share count.

Flagship explainer

How Synergy CHC Corp. makes its money

Start with a dollar of revenue and follow what the filing says remains.

Honest partial: the filing did not provide a normalized tag for Research and development, Selling, general and administrative; those components are omitted, not plugged.

Table alternative
Filed line	Value	% of revenue	Source
	$30.4M	100%	10-K · FY 2025Filing detailsAccession 0001213900-26-037883 · filed Apr 1, 2026
Cost of revenue	$10.1M	33%	10-K · FY 2025Filing detailsAccession 0001213900-26-037883 · filed Apr 1, 2026
	$20.3M	67%	10-K · FY 2025Filing detailsAccession 0001213900-26-037883 · filed Apr 1, 2026
	−$8.5M	−28%	10-K · FY 2025Filing detailsAccession 0001213900-26-037883 · filed Apr 1, 2026
Income before tax	−$12.2M	−40%	10-K · FY 2025Filing detailsAccession 0001213900-26-037883 · filed Apr 1, 2026
Income tax	$117471	0%	10-K · FY 2025Filing detailsAccession 0001213900-26-037883 · filed Apr 1, 2026
	−$12.3M	−41%	10-K · FY 2025Filing detailsAccession 0001213900-26-037883 · filed Apr 1, 2026

Source:

10-K · FY 2025Filing detailsAccession 0001213900-26-037883 · filed Apr 1, 2026

· event Dec 31, 2025 · retrieved Sep 30, 2026 · annual-row source set

Embed this chart

Flagship explainer

What Synergy CHC Corp. owns — and owes

Synergy CHC Corp.'s filing tags don't support a full breakdown — here's what is filed:

Table alternative
Filed line	Value	% of assets	Source
Total assets	$10.2M	100%	10-K · FY 2025Filing detailsAccession 0001213900-26-037883 · filed Apr 1, 2026
Cash and equivalents	$2.6M	26%	10-K · FY 2025Filing detailsAccession 0001213900-26-037883 · filed Apr 1, 2026
	$25.1M	247%	10-K · FY 2025Filing detailsAccession 0001213900-26-037883 · filed Apr 1, 2026
Stockholders’ equity	−$23.1M	−228%	10-K · FY 2025Filing detailsAccession 0001213900-26-037883 · filed Apr 1, 2026

Source:

10-K · FY 2025Filing detailsAccession 0001213900-26-037883 · filed Apr 1, 2026

· event Dec 31, 2025 · retrieved Sep 30, 2026 · annual-row source set

Flagship explainer

What drives Synergy CHC Corp.’s return on equity?

ROE is five filed business factors multiplied together.

DuPont source inputs
Input	Value	Fiscal year	Source
	−$12.3M	FY2025	10-K · FY 2025Filing detailsAccession 0001213900-26-037883 · filed Apr 1, 2026
Income before tax	−$12.2M	FY2025	10-K · FY 2025Filing detailsAccession 0001213900-26-037883 · filed Apr 1, 2026
Operating income	−$8.5M	FY2025	10-K · FY 2025Filing detailsAccession 0001213900-26-037883 · filed Apr 1, 2026
	$30.4M	FY2025	10-K · FY 2025Filing detailsAccession 0001213900-26-037883 · filed Apr 1, 2026
Ending assets	$10.2M	FY2025	10-K · FY 2025Filing detailsAccession 0001213900-26-037883 · filed Apr 1, 2026
Beginning assets	$16.3M	FY2024	10-K · FY 2024Filing detailsAccession 0001213900-25-026254 · filed Mar 31, 2025 10-K · FY 2024Filing detailsAccession 0001213900-26-037883 · filed Apr 1, 2026
	−$23.1M	FY2025	10-K · FY 2025Filing detailsAccession 0001213900-26-037883 · filed Apr 1, 2026
	−$16.6M	FY2024	10-K · FY 2024Filing detailsAccession 0001213900-25-026254 · filed Mar 31, 2025 10-K · FY 2024Filing detailsAccession 0001213900-26-037883 · filed Apr 1, 2026

Source:

10-K · filed Mar 31, 2025Filing detailsAccession 0001213900-25-026254 · filed Mar 31, 2025
10-K · filed Apr 1, 2026Filing detailsAccession 0001213900-26-037883 · filed Apr 1, 2026

· event Dec 31, 2025 · retrieved Sep 30, 2026 · annual-row source set

Embed this chart

Flagship explainer

Where Synergy CHC Corp.'s cash went

Synergy CHC Corp.’s filing does not supply enough provenance-matched cash-flow lines for a truthful flow chart — here’s what is filed:

Table alternative
Filed line	Value	% of cash from operations	Source
Cash from operations	−$2.6M	−100%	10-K · FY 2025Filing detailsAccession 0001213900-26-037883 · filed Apr 1, 2026
Depreciation and amortization	$133334	5%	10-K · FY 2025Filing detailsAccession 0001213900-26-037883 · filed Apr 1, 2026

Source:

10-K · FY 2025Filing detailsAccession 0001213900-26-037883 · filed Apr 1, 2026

· event Dec 31, 2025 · retrieved Sep 30, 2026 · annual-row source set

Curated 19-manager tier

Who reported holding Synergy CHC Corp.

Delayed public 13F reports for 2026-Q2—not live positions, trades, or recommendations.

0 holding0 exited0 not holding0/19 resolved19 not retrieved

Named manager positions and quarter-over-quarter changes
Manager	Reported position	Quarter-over-quarter	Filing accession
Abrams Capital	Not retrieved	Comparison not retrieved	Filing not retrieved
Akre Capital	Not retrieved	Comparison not retrieved	Filing not retrieved
Baupost Group	Not retrieved	Comparison not retrieved	Filing not retrieved
Berkshire Hathaway	Not retrieved	Comparison not retrieved	Filing not retrieved
Brave Warrior Advisors	Not retrieved	Comparison not retrieved	Filing not retrieved
Dodge & Cox	Not retrieved	Comparison not retrieved	Filing not retrieved
First Eagle	Not retrieved	Comparison not retrieved	Filing not retrieved
Fundsmith	Not retrieved	Comparison not retrieved	Filing not retrieved
Gardner Russo & Quinn	Not retrieved	Comparison not retrieved	Filing not retrieved
Gates Foundation Trust	Not retrieved	Comparison not retrieved	Filing not retrieved
Mairs & Power	Not retrieved	Comparison not retrieved	Filing not retrieved
Markel / Markel-Gayner	Not retrieved	Comparison not retrieved	Filing not retrieved
Oakmark / Harris Associates	Not retrieved	Comparison not retrieved	Filing not retrieved
Pershing Square	Not retrieved	Comparison not retrieved	Filing not retrieved
Polen Capital	Not retrieved	Comparison not retrieved	Filing not retrieved
Sequoia / Ruane Cunniff	Not retrieved	Comparison not retrieved	Filing not retrieved
Southeastern Asset Management	Not retrieved	Comparison not retrieved	Filing not retrieved
Tweedy, Browne	Not retrieved	Comparison not retrieved	Filing not retrieved
Yacktman Asset Management	Not retrieved	Comparison not retrieved	Filing not retrieved

Position size uses shares and filed value from each manager’s 13F. Portfolio weight uses the eligible long-share filing denominator. Changes compare only with the immediately preceding calendar quarter.

Source: Filing source not retrieved · event Jun 30, 2026 · retrieved Sep 30, 2026

Flagship explainer

What Synergy CHC Corp. insiders reported

Records still being gathered — partial as of retrieval Sep 30, 2026.

Partial coverage: the incomplete Form 4 walk cannot establish no activity, an activity date, or zero counts.

Moat Score history

Moat Score over timeLast scored reading of each day, on the 0–100 scale42.3 / 100

Score history begins Sep 30, 2026 — the record builds forward from here.

Tier changesSame-methodology and same-normalizer crossings of the Wide / Narrow / Shallow bars

None yet — SNYRQ has read Shallow moat for every logged capture since Sep 30, 2026.

Scores are logged append-only and never overwritten — this record cannot be reconstructed retroactively, which is exactly why it’s worth keeping.

Insider activity

Form 4 reports mix P/S market or private transactions with compensation-plan mechanics. Activity casually described as “insider selling” can include compensation mechanics; awards, tax withholding, and option exercises are shown by their exact filed class here, never collapsed into “Bought” or “Sold.”

These are disclosed filing facts and arithmetic aggregates, not a signal or verdict.

This machine-readable surface covers SEC ownership filings from 2003; it does not represent earlier paper-era records.

Records still being gathered — partial as of retrieval Sep 30, 2026.

Trailing-12-month totals and the 90-day cluster result are withheld because this issuer walk is incomplete.

No reported Form 4 rows were captured for SNYRQ; the incomplete walk cannot establish zero activity, zero counts, or a negative cluster result.

A filing source-event date will appear when a Form 4 row is captured.

Retrieved Sep 30, 2026.

Healthcare context

Outside the top 500 of 711 scored Healthcare companies by Moat Score.

Healthcare leaders by Moat Score

#1IDXX IDEXX LABORATORIES INC /DE96.2 out of 100, Wide moatWide moat
#2LLY ELI LILLY AND COMPANY94.3 out of 100, Wide moatWide moat
#3RMD ResMed Inc.93.8 out of 100, Wide moatWide moat

Compare SNYRQ with Healthcare leaders →All Healthcare companies on the Index →

Common questions about SNYRQ

Does Synergy CHC Corp. have an economic moat?: Based on its FY2025 SEC filings, the Moat Index scores Synergy CHC Corp. (SNYRQ) 42.3 out of 100 — a Shallow moat. The five questions behind that score begin at 20% each; if exactly one genuinely lacks data, the other four weights are renormalized and disclosed. revenue and EPS trend 0, pricing power 85, returns on capital 75, balance-sheet safety 28, capital allocation 24.
How has SNYRQ's Moat Score changed over time?: The record logs 1 reading since Sep 30, 2026; the latest reads 42.3 out of 100 (shallow moat). No tier changes on record yet. The history is append-only — readings are only ever added, never rewritten.

Scored from primary SEC filings via the public methodology. Educational only — not a recommendation to buy or sell SNYRQ. See the disclaimer.